Autologous fat transplant is an emerging regenerative approach that uses your own fatty tissue to treat osteoarthritis in joints such as the hands and knees. The procedure involves harvesting small amounts of adipose tissue (fatty tissue) from areas such as the abdomen or thighs, processing it to concentrate healing components, and injecting it into affected joints.
Unlike synthetic fillers or standard medications, this biological treatment uses the body’s own cells—including mesenchymal stem cells (specialised cells that can differentiate into different tissue types) and growth factors (proteins that support healing)—to potentially reduce inflammation and promote tissue repair.
How Autologous Fat Transplant Works
The autologous fat transplant process is a streamlined, single-session procedure performed in Singapore clinics that leverages your body’s own regenerative cells to treat joint discomfort and laxity.
- Adipose Harvesting: Under local anaesthesia, a small-volume liposuction extracts fat tissue from donor sites such as the abdomen or thighs, ensuring a minimally invasive start to the procedure.
- Precision Processing: The harvested tissue is refined through mechanical filtering or enzymatic digestion to isolate the stromal vascular fraction—a potent concentrate of stem cells and growth factors that drive tissue repair.
- Targeted Injection: Using the arthrocentesis technique, the doctor precisely delivers the concentrated cells into the joint cavity, with the entire process typically completed within one to two hours.
Biological Mechanisms in Joint Treatment
Adipose tissue contains mesenchymal stem cells capable of differentiating into various cell types. When introduced into an osteoarthritic joint, these cells encounter an inflammatory environment with damaged cartilage and altered synovial fluid (the lubricating fluid inside joints).
How it may work:
The therapeutic effect is thought to involve multiple mechanisms, though the exact processes are still being researched:
- Anti-inflammatory action: Injected stem cells may secrete signalling molecules (cytokines) that help calm chronic inflammation
- Growth factor release: These cells may release proteins that support existing cartilage cells and tissue balance
- Mechanical cushioning: The adipose tissue itself acts as a biological cushion within the joint space, potentially reducing bone-on-bone contact
The survival of transplanted fat within joints remains under investigation. Some grafted tissue may integrate and persist, while portions may be reabsorbed over time. Many patients require repeat injections to maintain benefits, though the timeline varies considerably.
Hand Osteoarthritis Applications
Hand osteoarthritis commonly affects the following areas:
- The base of the thumb (carpometacarpal joint)
- Finger joints near the nail (distal interphalangeal joints)
- Middle finger joints (proximal interphalangeal joints)
These small joints bear significant loads during gripping and pinching, making degeneration particularly disabling for daily activities.
Autologous fat transplant for hand osteoarthritis targets patients who have not responded adequately to splinting, therapy, and oral medications but wish to delay or avoid joint fusion or replacement surgery. The base of the thumb, frequently affected and functionally important, receives particular attention in clinical practice.
The injection technique for hand joints requires precision due to their small size. Fluoroscopic or ultrasound guidance (imaging methods that help the physician see inside the body in real time) helps ensure accurate placement within the joint capsule. Volumes injected are typically small—often less than one millilitre per joint—to avoid overdistension.
Recovery following hand joint injection generally allows return to light activities within days. Patients are advised to avoid heavy loading of the treated joints for several weeks. Grip strength improvements and pain reduction may develop gradually over weeks to months as the biological effects manifest.
Knee Osteoarthritis Treatment
The knee is a common target for autologous fat transplant due to its larger joint space, which accommodates greater volumes of fat graft for both cushioning and biological effects.]
The injection uses standard knee access points, with volumes typically ranging from 5 to 20 millilitres, depending on the processing method. Some practitioners combine fat injection with arthroscopic debridement (a minimally invasive procedure that uses a small camera to remove damaged tissue), thereby allowing direct visualisation of cartilage damage.
Comparison with Other Joint Injections
Corticosteroid Injections
Corticosteroid injections (medications that reduce inflammation) provide rapid anti-inflammatory effects but carry risks of cartilage damage with repeated use and offer no regenerative potential. Their effects typically last weeks to months, requiring periodic re-injection for ongoing benefit.
Hyaluronic Acid/Viscosupplementation
Hyaluronic acid/viscosupplementation (injections of a gel-like substance that mimics natural joint fluid) aims to restore joint fluid properties and may provide cushioning and lubrication. Effects vary considerably between patients. The treatment requires multiple injections over several weeks per course.
Platelet-Rich Plasma
Platelet-rich plasma (a concentrated preparation of your own blood’s healing components) concentrates growth factors from blood but lacks the stem cell component found in adipose tissue. The two approaches share some mechanisms and are sometimes combined in clinical practice.
Autologous Fat Transplant
Autologous fat transplantation provides both cellular and mechanical contributions. Stem cells offer regenerative potential, whereas the fat itself provides physical cushioning. However, the procedure is more invasive than simple injections, requiring liposuction to harvest fat.
💡 Did You Know?
Adipose tissue contains substantially more mesenchymal stem cells per gram than bone marrow, making it a suitable source for regenerative applications.
What to Expect
Reported outcomes in clinical studies:
Patients in published studies have reported:
- Reductions in pain scores (typically measured on standardised scales)
- Improvements in range of motion
- Enhanced quality of life measures
- Better ability to perform daily activities
Important context:
Imaging studies rarely show actual cartilage regeneration, even when patients feel better. Some studies report “stabilisation” of cartilage loss—meaning the joint doesn’t worsen as quickly—but this finding is inconsistent. The gap between symptom improvement and structural changes suggests that pain relief may result from reduced inflammation and increased cushioning rather than from tissue repair.
Who tends to have better outcomes:
Patient selection significantly influences results. Those who tend to report better outcomes include:
- Patients with mild to moderate (rather than severe) osteoarthritis
- Those with localised cartilage damage (not widespread degeneration)
- Patients without significant limb malalignment or deformity
- Individuals with good overall health and no inflammatory arthritis conditions
Setting realistic expectations:
This treatment may reduce pain and improve function for some patients, but it:
- Does not cure or reverse osteoarthritis
- Does not eliminate the underlying degenerative process
- May require repeat treatments to maintain benefits
- Does not prevent the possible need for joint replacement surgery in the future
Procedure Safety and Recovery
Common side effects:
Most patients experience mild, temporary effects, including:
At the donor site (where fat is harvested):
- Bruising, swelling, and tenderness
- Temporary numbness or altered sensation
- Minor discomfort during movement
At the injection site (treated joint):
- Joint swelling and stiffness for several days
- Temporary increase in pain (typically resolves within a week)
- Warmth or fullness sensation in the joint
Safety monitoring:
Because this is an emerging treatment, long-term safety data beyond 2-3 years is limited. Patients undergoing this procedure should:
- Attend all scheduled follow-up appointments
- Report any unusual symptoms promptly
- Understand that unforeseen long-term effects, while unlikely, cannot be completely ruled out
Recovery timelines:
Recovery varies based on which joint is treated:
Hand joints:
- Return to desk work: 2-5 days
- Light gripping activities: 1-2 weeks
- Full manual tasks: 4-6 weeks
Knee joints:
- Walking without assistance: 3-7 days
- Return to work (sedentary): 1 week
- Impact activities (running, jumping): 3-4 months
- Sports participation: 4-6 months, with physician clearance
Follow-up appointments will assess your treatment response and guide the timing of safely increasing activity levels.
Preparing for Treatment
Medical evaluation confirms the diagnosis of osteoarthritis and excludes other conditions that might affect treatment suitability. Imaging studies (such as X-rays or MRIs) document baseline joint status for comparison. Blood tests may screen for conditions that affect healing or increase the risk of infection.
Patients should disclose all medications, particularly blood thinners that require adjustment before the procedure. Anti-inflammatory medications may be paused during treatment, as their effects could theoretically interfere with the regenerative process.
Identifying adequate donor sites ensures sufficient fat can be harvested. Very lean patients may have limited options, which may affect candidacy. The harvest site should be discussed in advance, as it may experience temporary bruising and require post-procedural care.
Arranging transportation home is necessary since the procedure involves local anaesthesia and potentially light sedation. Reducing activity in the days following treatment helps ensure adequate rest during the initial healing phase.
When to Consider Evaluation
You may wish to discuss treatment options with an orthopaedic specialist if you experience:
- Persistent joint pain that continues despite rest, ice, and over-the-counter medications for several weeks
- Morning stiffness in hands or knees lasting more than 30 minutes
- Functional limitations such as:
- Difficulty opening jars, turning keys, or buttoning clothes (hand OA)
- Limited walking distance or trouble with stairs (knee OA)
- Progressive symptoms where previous treatments (therapy, splints, medications) are providing diminishing relief
- Interest in exploring options before considering joint fusion or replacement surgery
Commonly Asked Questions
Can this treatment cure my osteoarthritis?
No. This treatment does not cure or reverse osteoarthritis. The goal is symptom management—potentially reducing pain and improving function—but the underlying degenerative process continues. Some patients eventually require joint replacement surgery despite initial improvement from fat transplant. Think of this as one tool in managing a chronic condition, not a permanent solution.
Can an autologous fat transplant be combined with other treatments?
Combination approaches are common in clinical practice. Some surgeons perform arthroscopic procedures simultaneously, addressing mechanical issues while delivering the fat graft. Physical therapy remains important regardless of injection treatment. Ongoing use of supportive devices, such as splints, may be required.
Who is not a suitable candidate for this procedure?
Patients with active joint infection, bleeding disorders, or insufficient donor fat may not be candidates. Individuals with inflammatory arthritis, such as rheumatoid arthritis, require careful evaluation. Extremely advanced osteoarthritis with complete cartilage loss and significant deformity may be better addressed with surgical reconstruction.
How does this differ from stem cell injections I’ve heard about?
Autologous fat transplantation delivers stem cells into their native tissue environment rather than as isolated cells. Adipose tissue provides scaffolding, growth factors, and mechanical properties, alongside its cellular components. Some “stem cell” treatments use bone marrow or require in vitro expansion, representing distinct approaches with distinct characteristics.
Conclusion
Autologous fat transplant delivers both stem cells and mechanical cushioning for symptomatic hand and knee osteoarthritis. The procedure involves harvesting your own adipose tissue through liposuction and injecting it into affected joints to reduce inflammation and potentially support tissue repair.
While results vary, appropriate candidates may experience pain reduction and functional improvement, though the treatment does not reverse the underlying degenerative process.
If you’re experiencing persistent joint pain, grip weakness, or limited mobility in your hands or knees, a specialist hand and orthopaedic surgeon can evaluate whether an autologous fat transplant is suitable for your specific condition.
